You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chidamide

Showing 26 - 50 of 77
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Safety and Efficacy Trial in Suzhou (Chidamide)

Recruiting
  • Safety and Efficacy
  • Chidamide
  • Suzhou, Jiangsu, China
    First Affiliated Hospital,Soochow University
Nov 30, 2021

Leukemia, Myeloid, Acute Trial in Guanzhou (Azacitidine, Chidamide)

Recruiting
  • Leukemia, Myeloid, Acute
  • Guanzhou, Guandong, China
    Nanfang Hospital of Southern Medical University
Mar 6, 2022

Leukemia, Leukemia, Acute, Leukemia, Lymphoblastic Trial in Guangzhou (Chidamide, Dasatinib)

Recruiting
  • Leukemia
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Hematology, Nanfang Hospital
Jun 28, 2022

Safety and Efficacy Trial in Guangzhou, Wuhan (Sintilimab, Chidamide)

Completed
  • Safety and Efficacy
  • Guangzhou, Guangdong, China
  • +3 more
Apr 6, 2022

Peripheral T-Cell Lymphoma Trial in Zhengzhou (Parsaclisib, Chidamide)

Not yet recruiting
  • Peripheral T-Cell Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Dec 26, 2021

Non Hodgkin's Lymphoma Trial in China (Chidamide, Fludarabine and cyclophosphamide, Anti-CD19 CAR-T cells)

Recruiting
  • Non Hodgkin's Lymphoma
  • Chidamide
  • +2 more
  • Beijing, Beijing, China
  • +12 more
Jun 9, 2022

Neuroendocrine Tumors, Neuroendocrine Tumor Grade 3, Neuroendocrine Carcinoma Trial in Xiamen, Harbin (Chidamide, Sintilimab)

Recruiting
  • Neuroendocrine Tumors
  • +3 more
  • Xiamen, Fujian, China
  • +1 more
Nov 22, 2021

Advanced Breast Cancer Trial in Shenyang (Chidamide, Fulvestrant)

Recruiting
  • Advanced Breast Cancer
  • Shenyang, Liaoning, China
    Liangning Tumor Hospital &Institute
Sep 8, 2021

Non Small Cell Lung Cancer Trial in China (Chidamide, Envafolimab)

Recruiting
  • Non Small Cell Lung Cancer
  • Hefei, Anhui, China
  • +11 more
Jan 17, 2022

Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Beijing, Xiamen, Harbin (Chidamide, Etoposide + Cisplatin/Carboplatin)

Recruiting
  • Neuroendocrine Tumors
  • Neuroendocrine Carcinoma
  • Chidamide
  • Etoposide + Cisplatin/Carboplatin
  • Beijing, Beijing, China
  • +2 more
Nov 2, 2021

Breast Cancer Trial in China (Chidamide, exemestane, )

Completed
  • Breast Cancer
  • Chidamide
  • +2 more
  • Hefei, Anhui, China
  • +21 more
Jan 10, 2022

Angioimmunoblastic T-cell Lymphoma Trial in Guangzhou (Sintilimab, Chidamide)

Not yet recruiting
  • Angioimmunoblastic T-cell Lymphoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Apr 2, 2021

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma (NHL) Trial in Guangzhou (Chidamide)

Recruiting
  • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma (NHL)
  • Chidamide
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-sen University Cancer Ce
Mar 12, 2021

Safety and Efficacy Trial in Guangzhou (Sintilimab, Chidamide, Azacitidine)

Not yet recruiting
  • Safety and Efficacy
  • Guangzhou, Guangdong, China
    Department of Medical Oncology,Sun Yat-sen University Cancer Cen
Aug 16, 2021

Peripheral T-cell Lymphoma Trial in Beijing (Sintilimab, Chidamide, Azacidine)

Not yet recruiting
  • Peripheral T-cell Lymphoma
  • Beijing, Beijing, China
    Beijing
Mar 5, 2021

NHL, Adult Trial in Zhengzhou, Shanghai, Nanyang (APG-1252, Chidamide)

Recruiting
  • NHL, Adult
  • Zhengzhou, Henanan, China
  • +3 more
Jul 27, 2022

Advanced Microsatellite Stable Colorectal Cancer, Metastatic Microsatellite-stable Colorectal Cancer Trial (Sintilimab,

Not yet recruiting
  • Advanced Microsatellite Stable Colorectal Cancer
  • Metastatic Microsatellite-stable Colorectal Cancer
  • (no location specified)
Feb 3, 2021

NSCLC Trial in Guangzhou (Avitinib Maleate, Afatinib, Crizotinib)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Avitinib Maleate
  • +13 more
  • Guangzhou, Guangdong, China
    Guangdong Lung Cancer Institute, Guangdong Provincial People's H
Dec 3, 2022

Peripheral T Cell Lymphoma Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome Injection, Chidamide)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • Mitoxantrone Hydrochloride Liposome Injection
  • Chidamide
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 11, 2020

Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell Trial in China (Chidamide, Cladribine, Gemcitabine)

Recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, T-Cell
  • Chidamide
  • +8 more
  • Deyang, Deyang, China
  • +10 more
Jul 21, 2022

Lymphoma, Large B-Cell, Diffuse, Mantle Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Nanjing (Chidamide)

Active, not recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • +3 more
  • Chidamide
  • Nanjing, Jiangsu, China
    Hematological Department, People's Hospital of Jiangsu Province
Dec 30, 2021

Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden Trial in Beijing (Chidamide, Decitabine, Chidamide and

Unknown status
  • Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden
  • Chidamide
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinese PLA General Hospital
Dec 3, 2020

Hodgkin Lymphoma Trial in Beijing (Chidamide, Camrelizumab, Decitabine)

Recruiting
  • Hodgkin Lymphoma
  • Chidamide
  • +2 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinese PLA General Hospital
Aug 12, 2020

Non Hodgkin Lymphoma Trial in Beijing (Chidamide, Decitabine, Camrelizumab)

Recruiting
  • Non Hodgkin Lymphoma
  • Chidamide
  • +2 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinese PLA General Hospital
Apr 4, 2020

Diffuse Large B Cell Lymphoma Trial in Shanghai (Cyclophosphamide, Rituximab, Doxorubicin)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Shanghai, Shanghai, China
    Ruijin hospital
Nov 17, 2020